Aucta Pharmaceuticals Incis A Technology Driven Pharmaceutical Company Based In Piscatawaynjwith Operations In Shanghaichinathe Company Focuses On Developing Enhanced Therapeutics By Innovating Proven Moleculesparticularly In The Areas Of Cnsophthalmologyand Inhalation Therapiesaucta Operates With A Hybrid Branded And Generic Modelintegrating Research And Developmentmanufacturingand Commercialization To Meet Unmet Medical Needs The Company Has A Strong Emphasis On Improving Drug Delivery And Patient Outcomes Through Scientifically Validated Moleculesaucta S Product Portfolio Includes Fda Approved Motpoly Xran Extended Release Capsule For Seizuresand Vigadroneused For Refractory Epilepsy And Infantile Spasmstheir Strategy Combines Immediate Revenue From Generics With The Development Of Branded Productstargeting Healthcare Providers Such As Neurologists And Specialists In Respiratory And Ophthalmic Careaucta Is Committed To Patient Centric Innovation And Has Plans To Expand Its Commercial Capabilities In The U Smarket
